Simplex Trading
DMRA

Simplex Trading’s Damora Therapeutics DMRA Stock Holding History

Simplex Trading’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-26
Closed – – 8886
2024
Q2 		$0 Buy
26
+4
+18% +$63 ﹤0.01% 9147
2024
Q1 		$0 Buy
22
+19
+633% +$338 ﹤0.01% 9227
2023
Q4 		$0 Sell
3
-546
-99% -$8.4K ﹤0.01% 9169
2023
Q3 		$9K Buy
549
+93
+20% +$3.65K ﹤0.01% 7246
2023
Q2 		$28K Buy
456
+444
+3,700% +$24.2K ﹤0.01% 6419
2023
Q1 		$0 Buy
+12
New +$633 ﹤0.01% 9402
2022
Q4 		– Sell
-384
Closed -$18K – 9608
2022
Q3 		$18K Buy
384
+365
+1,921% +$18.5K ﹤0.01% 7624
2022
Q2 		$0 Buy
19
+16
+533% +$734 ﹤0.01% 10345
2022
Q1 		$0 Sell
3
-19
-86% -$1.07K ﹤0.01% 10746
2021
Q4 		$1K Buy
+22
New +$1.73K ﹤0.01% 10188

Other funds holding DMRA

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Simplex Trading's DMRA Position: Q3 2024 in Review

Simplex Trading sold out of Damora Therapeutics (DMRA) in Q3 2024, closing a stake of 26 shares.

Simplex Trading first reported a position in DMRA in Q4 2021 and held it in 10 quarters. The position peaked at $28K in Q2 2023. 10 funds tracked by Wall St. Rank hold DMRA as of Q3 2024.

  • Simplex Trading reported no remaining Damora Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 26 Damora Therapeutics shares in Q3 2024.
  • Simplex Trading first reported a position in Damora Therapeutics in Q4 2021 and held it in 10 quarters.
  • Simplex Trading's Damora Therapeutics position peaked at $28K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Damora Therapeutics as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.